UK markets closed
  • FTSE 100

    7,134.06
    +45.88 (+0.65%)
     
  • FTSE 250

    22,734.13
    +125.37 (+0.55%)
     
  • AIM

    1,249.65
    +3.03 (+0.24%)
     
  • GBP/EUR

    1.1648
    +0.0009 (+0.07%)
     
  • GBP/USD

    1.4117
    -0.0060 (-0.42%)
     
  • BTC-GBP

    24,798.06
    -300.12 (-1.20%)
     
  • CMC Crypto 200

    924.19
    -17.62 (-1.87%)
     
  • S&P 500

    4,247.44
    +8.26 (+0.19%)
     
  • DOW

    34,479.60
    +13.36 (+0.04%)
     
  • CRUDE OIL

    70.78
    +0.49 (+0.70%)
     
  • GOLD FUTURES

    1,879.50
    -16.90 (-0.89%)
     
  • NIKKEI 225

    28,948.73
    -9.83 (-0.03%)
     
  • HANG SENG

    28,842.13
    +103.25 (+0.36%)
     
  • DAX

    15,693.27
    +122.05 (+0.78%)
     
  • CAC 40

    6,600.66
    +54.17 (+0.83%)
     

U.S. support for COVID patent waiver will push WTO talks, says WTO chief

·1-min read
FILE PHOTO: WTO Director-General Ngozi poses before an interview with Reuters at the WTO headquarters in Geneva

ROME (Reuters) - A United States' proposal to discuss waiving patent protections for COVID-19 vaccines will intensify talks on the issue within the World Trade Organisation, the WTO director general said on Friday.

Speaking at an online conference, Ngozi Okonjo-Iweala said there were arguments for and against a waiver, but she was "sure (the proposal) will give impetus" to negotiations.

Aside from the patent issue, the WTO chief said there were other aspects that needed to be addressed to improve vaccine supplies, such as reducing export restrictions so that supply chains can work efficiently.

At the event organised by the European University Institute in Florence, Okonjo-Iweala said it was also necessary to increase production capacity in emerging countries, noting that Africa currently imports almost all its vaccines.

She said she hoped WTO members would "come together" to address all these issues to help increase vaccine volumes.

(Reporting By Gavin Jones, editing by Angelo Amante)